Genetic context alone does not determine whether special issuance will be approved
Most common adverse reactions for Wegovy (semaglutide) The most common adverse reactions for Wegovy (incidence 5%) are nausea, diarrhea, vomiting, constipation, abdominal pain, dysesthesia, headache, fatigue, dyspepsia, dizziness, abdominal distension, eructation, hypoglycemia in patients with type 2 diabetes, flatulence, gastroenteritis, gastroesophageal reflux disease, and hair loss
The clinical implication: if you're in week 4 of a dose and weight loss has slowed, that's expected
This medication works by mimicking GLP-1 (glucagon-like peptide-1) , a natural hormone that regulates blood sugar, slows gastric emptying, enhances insulin release, and reduces appetite
Knowing the difference between a normal side effect and an electrolyte deficiency can change everything
It is possible, but the quality of weight loss is significantly worse without resistance training, especially for HRT users whose muscle mass is already vulnerable